{"id":143511,"date":"2020-04-22T10:20:38","date_gmt":"2020-04-22T10:20:38","guid":{"rendered":"https:\/\/www.bnreport.com\/allergy-therapeutics-welcomes-academic-papers-endorsement-of-adjuvant-technology\/"},"modified":"2020-04-22T10:20:38","modified_gmt":"2020-04-22T10:20:38","slug":"allergy-therapeutics-welcomes-academic-papers-endorsement-of-adjuvant-technology","status":"publish","type":"post","link":"https:\/\/www.bnreport.com\/en\/allergy-therapeutics-welcomes-academic-papers-endorsement-of-adjuvant-technology\/","title":{"rendered":"Allergy Therapeutics welcomes academic paper\u2019s endorsement of adjuvant technology"},"content":{"rendered":"

Allergy Therapeutics PLC<\/a> (LON:AGY<\/a>) has welcomed the publication of an academic paper endorsing the approach it has taken in using adjuvant technology for allergy immunotherapies.<\/p>\n

The paper, \u201cState-of-the-art in marketed adjuvants and formulations in Allergen Immunotherapy: a position paper of the European Academy of Allergy and Clinical Immunology (EAACI)\u201d, in the journal Allergy, was written by an independent taskforce of EAACI members and co-authored by the Paul-Ehrlich-Institut.<\/p>\n

READ: Allergy Therapeutics hails "steady" first half performance; finnCap ups forecasts<\/a>[hhmc]
\n<\/h4>\n

It includes a review of adjuvants and formulations currently used in marketed allergy immunotherapies.<\/p>\n

The AIM-listed allergy vaccines specialist said adjuvant technology, which can create immunotherapies that act faster and more efficiently than traditional therapies, is a key element of its strategy.<\/p>\n

Through its Bencard Adjuvant Systems division, the group has long-term partners requiring its patented platform of adjuvant technologies in areas outside allergy.<\/p>\n

Two adjuvants used by Allergy Therapeutics in its immunotherapies \u2013 MPL and MCT \u2013 were included in the review, with the taskforce acknowledging each as safe and effective.<\/p>\n

The report's authors stated: \u201cAt present, and since its introduction into AIT in 1970, there are no specific safety concerns known for MCT. It can be anticipated that this fully biodegradable adjuvant will also in future studies not reveal side effects.\u201d<\/p>\n

\u201cOverall, adherence is a severe problem in all of the currently marketed allergen immunotherapy products, underlining the need for optimising AIT with novel adjuvants and enhanced efficacy towards true vaccine concepts,\u201d the authors concluded.<\/p>\n

The review recognised the importance of adjuvants in improving the insufficient adherence among patientRead More \u2013 Source<\/a>
\n[contf]
\n[contfnew]
\n <\/p>\n

Proactiveinvestors<\/a><\/h5>\n

[contfnewc]
\n[contfnewc]<\/p>\n","protected":false},"excerpt":{"rendered":"

Allergy Therapeutics PLC (LON:AGY) has welcomed the publication of an academic paper endorsing the a..<\/p>\n","protected":false},"author":1,"featured_media":143512,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[46],"tags":[],"class_list":["post-143511","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-politics"],"yoast_head":"\nAllergy Therapeutics welcomes academic paper\u2019s endorsement of adjuvant technology - Business News Report<\/title>\n<meta name=\"description\" content=\"Allergy Therapeutics PLC (LON:AGY) has welcomed the publication of an academic paper endorsing the a..\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.bnreport.com\/en\/allergy-therapeutics-welcomes-academic-papers-endorsement-of-adjuvant-technology\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Allergy Therapeutics welcomes academic paper\u2019s endorsement of adjuvant technology - Business News Report\" \/>\n<meta property=\"og:description\" content=\"Allergy Therapeutics PLC (LON:AGY) has welcomed the publication of an academic paper endorsing the a..\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.bnreport.com\/en\/allergy-therapeutics-welcomes-academic-papers-endorsement-of-adjuvant-technology\/\" \/>\n<meta property=\"og:site_name\" content=\"Business News Report\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/Business-NewsReport-328225811095934\/\" \/>\n<meta property=\"article:published_time\" content=\"2020-04-22T10:20:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.bnreport.com\/wp-content\/uploads\/2020\/04\/1587549300_2020-04-22-10-55-00_0670418b53643a476bb85e04278e96da.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"916\" \/>\n\t<meta property=\"og:image:height\" content=\"423\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"infopal11\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@BNReport\" \/>\n<meta name=\"twitter:site\" content=\"@BNReport\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"infopal11\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/allergy-therapeutics-welcomes-academic-papers-endorsement-of-adjuvant-technology\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/allergy-therapeutics-welcomes-academic-papers-endorsement-of-adjuvant-technology\\\/\"},\"author\":{\"name\":\"infopal11\",\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/#\\\/schema\\\/person\\\/19d1c5a2dd7f60584a09de4a7805d68f\"},\"headline\":\"Allergy Therapeutics welcomes academic paper\u2019s endorsement of adjuvant technology\",\"datePublished\":\"2020-04-22T10:20:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/allergy-therapeutics-welcomes-academic-papers-endorsement-of-adjuvant-technology\\\/\"},\"wordCount\":278,\"publisher\":{\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/allergy-therapeutics-welcomes-academic-papers-endorsement-of-adjuvant-technology\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.bnreport.com\\\/wp-content\\\/uploads\\\/2020\\\/04\\\/1587549300_2020-04-22-10-55-00_0670418b53643a476bb85e04278e96da.jpg\",\"articleSection\":[\"Politics\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/allergy-therapeutics-welcomes-academic-papers-endorsement-of-adjuvant-technology\\\/\",\"url\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/allergy-therapeutics-welcomes-academic-papers-endorsement-of-adjuvant-technology\\\/\",\"name\":\"Allergy Therapeutics welcomes academic paper\u2019s endorsement of adjuvant technology - Business News Report\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/allergy-therapeutics-welcomes-academic-papers-endorsement-of-adjuvant-technology\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/allergy-therapeutics-welcomes-academic-papers-endorsement-of-adjuvant-technology\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.bnreport.com\\\/wp-content\\\/uploads\\\/2020\\\/04\\\/1587549300_2020-04-22-10-55-00_0670418b53643a476bb85e04278e96da.jpg\",\"datePublished\":\"2020-04-22T10:20:38+00:00\",\"description\":\"Allergy Therapeutics PLC (LON:AGY) has welcomed the publication of an academic paper endorsing the a..\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/allergy-therapeutics-welcomes-academic-papers-endorsement-of-adjuvant-technology\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.bnreport.com\\\/en\\\/allergy-therapeutics-welcomes-academic-papers-endorsement-of-adjuvant-technology\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/allergy-therapeutics-welcomes-academic-papers-endorsement-of-adjuvant-technology\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.bnreport.com\\\/wp-content\\\/uploads\\\/2020\\\/04\\\/1587549300_2020-04-22-10-55-00_0670418b53643a476bb85e04278e96da.jpg\",\"contentUrl\":\"https:\\\/\\\/www.bnreport.com\\\/wp-content\\\/uploads\\\/2020\\\/04\\\/1587549300_2020-04-22-10-55-00_0670418b53643a476bb85e04278e96da.jpg\",\"width\":916,\"height\":423},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/allergy-therapeutics-welcomes-academic-papers-endorsement-of-adjuvant-technology\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"\u0627\u0644\u0631\u0626\u064a\u0633\u064a\u0629\",\"item\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Allergy Therapeutics welcomes academic paper\u2019s endorsement of adjuvant technology\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/\",\"name\":\"Business News Report\",\"description\":\"Latest News on the World of Politics & Business\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/#organization\",\"name\":\"\u0628\u0632\u0646\u0633 \u0631\u064a\u0628\u0648\u0631\u062a \u0627\u0644\u0627\u062e\u0628\u0627\u0631\u064a\",\"url\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.bnreport.com\\\/wp-content\\\/uploads\\\/2020\\\/12\\\/LOGO2.png\",\"contentUrl\":\"https:\\\/\\\/www.bnreport.com\\\/wp-content\\\/uploads\\\/2020\\\/12\\\/LOGO2.png\",\"width\":200,\"height\":50,\"caption\":\"\u0628\u0632\u0646\u0633 \u0631\u064a\u0628\u0648\u0631\u062a \u0627\u0644\u0627\u062e\u0628\u0627\u0631\u064a\"},\"image\":{\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/Business-NewsReport-328225811095934\\\/\",\"https:\\\/\\\/x.com\\\/BNReport\",\"https:\\\/\\\/www.instagram.com\\\/business.newsreport\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/#\\\/schema\\\/person\\\/19d1c5a2dd7f60584a09de4a7805d68f\",\"name\":\"infopal11\",\"url\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/author\\\/infopal11\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Allergy Therapeutics welcomes academic paper\u2019s endorsement of adjuvant technology - Business News Report","description":"Allergy Therapeutics PLC (LON:AGY) has welcomed the publication of an academic paper endorsing the a..","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.bnreport.com\/en\/allergy-therapeutics-welcomes-academic-papers-endorsement-of-adjuvant-technology\/","og_locale":"en_US","og_type":"article","og_title":"Allergy Therapeutics welcomes academic paper\u2019s endorsement of adjuvant technology - Business News Report","og_description":"Allergy Therapeutics PLC (LON:AGY) has welcomed the publication of an academic paper endorsing the a..","og_url":"https:\/\/www.bnreport.com\/en\/allergy-therapeutics-welcomes-academic-papers-endorsement-of-adjuvant-technology\/","og_site_name":"Business News Report","article_publisher":"https:\/\/www.facebook.com\/Business-NewsReport-328225811095934\/","article_published_time":"2020-04-22T10:20:38+00:00","og_image":[{"width":916,"height":423,"url":"https:\/\/www.bnreport.com\/wp-content\/uploads\/2020\/04\/1587549300_2020-04-22-10-55-00_0670418b53643a476bb85e04278e96da.jpg","type":"image\/jpeg"}],"author":"infopal11","twitter_card":"summary_large_image","twitter_creator":"@BNReport","twitter_site":"@BNReport","twitter_misc":{"Written by":"infopal11","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.bnreport.com\/en\/allergy-therapeutics-welcomes-academic-papers-endorsement-of-adjuvant-technology\/#article","isPartOf":{"@id":"https:\/\/www.bnreport.com\/en\/allergy-therapeutics-welcomes-academic-papers-endorsement-of-adjuvant-technology\/"},"author":{"name":"infopal11","@id":"https:\/\/www.bnreport.com\/en\/#\/schema\/person\/19d1c5a2dd7f60584a09de4a7805d68f"},"headline":"Allergy Therapeutics welcomes academic paper\u2019s endorsement of adjuvant technology","datePublished":"2020-04-22T10:20:38+00:00","mainEntityOfPage":{"@id":"https:\/\/www.bnreport.com\/en\/allergy-therapeutics-welcomes-academic-papers-endorsement-of-adjuvant-technology\/"},"wordCount":278,"publisher":{"@id":"https:\/\/www.bnreport.com\/en\/#organization"},"image":{"@id":"https:\/\/www.bnreport.com\/en\/allergy-therapeutics-welcomes-academic-papers-endorsement-of-adjuvant-technology\/#primaryimage"},"thumbnailUrl":"https:\/\/www.bnreport.com\/wp-content\/uploads\/2020\/04\/1587549300_2020-04-22-10-55-00_0670418b53643a476bb85e04278e96da.jpg","articleSection":["Politics"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.bnreport.com\/en\/allergy-therapeutics-welcomes-academic-papers-endorsement-of-adjuvant-technology\/","url":"https:\/\/www.bnreport.com\/en\/allergy-therapeutics-welcomes-academic-papers-endorsement-of-adjuvant-technology\/","name":"Allergy Therapeutics welcomes academic paper\u2019s endorsement of adjuvant technology - Business News Report","isPartOf":{"@id":"https:\/\/www.bnreport.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.bnreport.com\/en\/allergy-therapeutics-welcomes-academic-papers-endorsement-of-adjuvant-technology\/#primaryimage"},"image":{"@id":"https:\/\/www.bnreport.com\/en\/allergy-therapeutics-welcomes-academic-papers-endorsement-of-adjuvant-technology\/#primaryimage"},"thumbnailUrl":"https:\/\/www.bnreport.com\/wp-content\/uploads\/2020\/04\/1587549300_2020-04-22-10-55-00_0670418b53643a476bb85e04278e96da.jpg","datePublished":"2020-04-22T10:20:38+00:00","description":"Allergy Therapeutics PLC (LON:AGY) has welcomed the publication of an academic paper endorsing the a..","breadcrumb":{"@id":"https:\/\/www.bnreport.com\/en\/allergy-therapeutics-welcomes-academic-papers-endorsement-of-adjuvant-technology\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.bnreport.com\/en\/allergy-therapeutics-welcomes-academic-papers-endorsement-of-adjuvant-technology\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.bnreport.com\/en\/allergy-therapeutics-welcomes-academic-papers-endorsement-of-adjuvant-technology\/#primaryimage","url":"https:\/\/www.bnreport.com\/wp-content\/uploads\/2020\/04\/1587549300_2020-04-22-10-55-00_0670418b53643a476bb85e04278e96da.jpg","contentUrl":"https:\/\/www.bnreport.com\/wp-content\/uploads\/2020\/04\/1587549300_2020-04-22-10-55-00_0670418b53643a476bb85e04278e96da.jpg","width":916,"height":423},{"@type":"BreadcrumbList","@id":"https:\/\/www.bnreport.com\/en\/allergy-therapeutics-welcomes-academic-papers-endorsement-of-adjuvant-technology\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"\u0627\u0644\u0631\u0626\u064a\u0633\u064a\u0629","item":"https:\/\/www.bnreport.com\/en\/"},{"@type":"ListItem","position":2,"name":"Allergy Therapeutics welcomes academic paper\u2019s endorsement of adjuvant technology"}]},{"@type":"WebSite","@id":"https:\/\/www.bnreport.com\/en\/#website","url":"https:\/\/www.bnreport.com\/en\/","name":"Business News Report","description":"Latest News on the World of Politics & Business","publisher":{"@id":"https:\/\/www.bnreport.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.bnreport.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.bnreport.com\/en\/#organization","name":"\u0628\u0632\u0646\u0633 \u0631\u064a\u0628\u0648\u0631\u062a \u0627\u0644\u0627\u062e\u0628\u0627\u0631\u064a","url":"https:\/\/www.bnreport.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.bnreport.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.bnreport.com\/wp-content\/uploads\/2020\/12\/LOGO2.png","contentUrl":"https:\/\/www.bnreport.com\/wp-content\/uploads\/2020\/12\/LOGO2.png","width":200,"height":50,"caption":"\u0628\u0632\u0646\u0633 \u0631\u064a\u0628\u0648\u0631\u062a \u0627\u0644\u0627\u062e\u0628\u0627\u0631\u064a"},"image":{"@id":"https:\/\/www.bnreport.com\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Business-NewsReport-328225811095934\/","https:\/\/x.com\/BNReport","https:\/\/www.instagram.com\/business.newsreport"]},{"@type":"Person","@id":"https:\/\/www.bnreport.com\/en\/#\/schema\/person\/19d1c5a2dd7f60584a09de4a7805d68f","name":"infopal11","url":"https:\/\/www.bnreport.com\/en\/author\/infopal11\/"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.bnreport.com\/en\/wp-json\/wp\/v2\/posts\/143511","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.bnreport.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.bnreport.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.bnreport.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bnreport.com\/en\/wp-json\/wp\/v2\/comments?post=143511"}],"version-history":[{"count":0,"href":"https:\/\/www.bnreport.com\/en\/wp-json\/wp\/v2\/posts\/143511\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.bnreport.com\/en\/wp-json\/wp\/v2\/media\/143512"}],"wp:attachment":[{"href":"https:\/\/www.bnreport.com\/en\/wp-json\/wp\/v2\/media?parent=143511"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.bnreport.com\/en\/wp-json\/wp\/v2\/categories?post=143511"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.bnreport.com\/en\/wp-json\/wp\/v2\/tags?post=143511"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}